Detalhe da pesquisa
1.
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma.
Neuropathol Appl Neurobiol
; 47(3): 379-393, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33080075
2.
Gliomatosis Cerebri Growth Pattern: Association of Differential First-Line Treatment with Overall Survival in WHO Grade II and III Gliomas.
Oncology
; 99(4): 215-224, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33472203
3.
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Lancet
; 393(10172): 678-688, 2019 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782343
4.
Quantitative T1 mapping indicates tumor infiltration beyond the enhancing part of glioblastomas.
NMR Biomed
; 33(3): e4242, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31880005
5.
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 20(10): 1444-1453, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31488360
6.
Fitting algorithms and baseline correction influence the results of non-invasive in vivo quantitation of 2-hydroxyglutarate with 1 H-MRS.
NMR Biomed
; 32(1): e4027, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30457203
7.
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
J Neurooncol
; 144(3): 501-509, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31325144
8.
Intracellular pH measured by 31 P-MR-spectroscopy might predict site of progression in recurrent glioblastoma under antiangiogenic therapy.
J Magn Reson Imaging
; 46(4): 1200-1208, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28165649
9.
Bevacizumab for Patients with Recurrent Multifocal Glioblastomas.
Int J Mol Sci
; 18(11)2017 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29156610
10.
Bevacizumab for Patients with Recurrent Gliomas Presenting with a Gliomatosis Cerebri Growth Pattern.
Int J Mol Sci
; 18(4)2017 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28353668
11.
Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entity.
Acta Neuropathol
; 131(2): 321-322, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26744347
12.
Gliomatosis cerebri: no evidence for a separate brain tumor entity.
Acta Neuropathol
; 131(2): 309-319, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26493382
13.
Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany.
Epilepsia
; 57(12): 2056-2066, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27753082
14.
Prognostic factors in recurrent glioblastoma patients treated with bevacizumab.
J Neurooncol
; 129(1): 93-100, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27193554
15.
Improved visibility of brain tumors in synthetic MP-RAGE anatomies with pure T1 weighting.
NMR Biomed
; 28(7): 818-30, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25960356
16.
Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas.
Acta Neuropathol
; 129(1): 115-31, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25322816
17.
Comprehensive diagnostics in a case of hereditary diffuse leukodystrophy with spheroids.
BMC Neurol
; 15: 103, 2015 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26141177
18.
Quantitative T1 and T2 mapping in recurrent glioblastomas under bevacizumab: earlier detection of tumor progression compared to conventional MRI.
Neuroradiology
; 57(1): 11-20, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25287076
19.
Confounding factors in diagnostics of MGMT promoter methylation status in glioblastomas in stereotactic biopsies.
Stereotact Funct Neurosurg
; 92(3): 129-39, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24776650
20.
MR perfusion in and around the contrast-enhancement of primary CNS lymphomas.
J Neurooncol
; 114(1): 127-34, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23695516